Advanced search
Publication Cover
Cancer Biology & Therapy Volume 21, 2020 - Issue 11
Submit an article Journal homepage
2,017
Views
6
CrossRef citations to date
0
Altmetric
Bedside-to-Bench Report

Ototoxicity in patients with invasive ductal breast cancer who were treated with docetaxel: report of two cases

Liang Xuana Department of Radiation Oncology, The Fifth Medical Center, Chinese PLA General Hospital, Beijing, China
,
Bing Suna Department of Radiation Oncology, The Fifth Medical Center, Chinese PLA General Hospital, Beijing, China
,
Xiangying Menga Department of Radiation Oncology, The Fifth Medical Center, Chinese PLA General Hospital, Beijing, China
,
Chao Liua Department of Radiation Oncology, The Fifth Medical Center, Chinese PLA General Hospital, Beijing, China
,
Yang Conga Department of Radiation Oncology, The Fifth Medical Center, Chinese PLA General Hospital, Beijing, China
&
Shikai Wub Department of Medical Oncology, Peking University First Hospital, Beijing, ChinaCorrespondence[email protected]
Pages 990-993 | Received 14 Jan 2019, Accepted 15 Sep 2020, Published online: 29 Oct 2020

References

  • J G Y, J N F, Kalinec F. 2006. Understanding drug ototoxicity: molecular insights for prevention and clinical management. Expert Opin Drug Saf. 5(3):383–399. doi:10.1517/14740338.5.3.383.
  • Crundwell G, Gomersall P, Baguley DM. Ototoxicity (cochleotoxicity) classifications: a review. Int J Audiol. 2016;55(2):65–74. doi:10.3109/14992027.2015.1094188. PMID: WOS:000366731300001.
  • L P R, Mukherjea D, Jajoo S, Ramkumar V. Cisplatin ototoxicity and protection: clinical and experimental studies. Tohoku J Exp Med. 2009;219(3):177–186. doi:10.1620/tjem.219.177. PMID: 19851045.
  • Jamesdaniel S, Coling D, Hinduja S, Ding D, Li J, Cassidy L, G M S, Qu J, Salvi R. 2012. Cisplatin-induced ototoxicity is mediated by nitroxidative modification of cochlear proteins characterized by nitration of lmo4. J Biol Chem. 287(22):18674–18686. doi:10.1074/jbc.M111.297960.
  • Paken J, C D G, Pillay M, Sewram V. Cisplatin-Associated ototoxicity: A review for the health professional. J Toxicol. 2016;2016:(1–13. doi:10.1155/2016/1809394.
  • Maclennan-Smith F, D W S, Hall JW. 2012. Validity of diagnostic pure-tone audiometry without a sound-treated environment in older adults. Int J Audiol. 52(2):66–73. doi:10.3109/14992027.2012.736692.
  • de Weger VA, J H B, Schellens JHM. Cellular and clinical pharmacology of the taxanes docetaxel and paclitaxel – a review. Anti-cancer Drug. 2014;25:(488–494. doi:10.1097/CAD.0000000000000093.
  • Baker J, Ajani J, Scotté F, Winther D, Martin M, M S A, von Minckwitz G. 2009. Docetaxel-related side effects and their management. Eur J Oncol Nurs. 13(1):49–59. doi:10.1016/j.ejon.2008.10.003.
  • C N F, S W L, H J G, Boven E. 2015. Genetic polymorphisms and paclitaxel- or docetaxel-induced toxicities: A systematic review. Cancer Treat Rev. 41(10):935–950. doi:10.1016/j.ctrv.2015.10.010.
  • Ho M, Mackey J. Presentation and management of docetaxel-related adverse effects in patients with breast cancer. Cancer Manag Res. 2014;6:(253–259. doi:10.2147/CMAR.S40601.
  • Atas A, Agca O, Sarac S, Poyraz A, Akyol MU. 2006. Investigation of ototoxic effects of Taxol on a mice model. Int J Pediatr Otorhi. 70(5):779–784. doi:10.1016/j.ijporl.2005.11.011.
  • Sarafraz M, Ahmadi K. Paraclinical evaluation of side-effects of Taxanes on auditory system. Acta otorhinolaryngologica Italica: organo ufficiale della Società italiana di otorinolaringologia e chirurgia cervico-facciale. 2008;28(5):239–242. PMID: 19186452.
  • Ridwelski K, Gebauer T, Fahlke J, Kröning H, Kettner E, Meyer F, Eichelmann K, Lippert H. 2001. Combination chemotherapy with docetaxel and cisplatin for locally advanced and metastatic gastric cancer. Ann Oncol. 12(1):47–51. doi:10.1023/A:1008328501128.
  • N W C, A M M, D J H, Lester E, P C H, Kozloff M, Lin S, J E D, Szeto L, Grushko T, et al. 2008. Phase i trial of Erlotinib-Based multimodality therapy for inoperable stage III non-small cell lung cancer. J Thorac Oncol. 3(9):1003–1011. doi:10.1097/JTO.0b013e31818396a4.
  • Youn C, Kim J, Jo E, Oh J, Do N, Cho S. 2016. Protective effect of tempol against cisplatin-induced ototoxicity. Int J Mol Sci. 17(11):1931. doi:10.3390/ijms17111931.
  • C K Y, Kim J, Park J, N Y D, Cho SI. 2015. Role of autophagy in cisplatin-induced ototoxicity. Int J Pediatr Otorhi. 79(11):1814–1819. doi:10.1016/j.ijporl.2015.08.012.
  • Dong Y, Ding D, Jiang H, Shi J, Salvi R, Roth JA. 2014. Ototoxicity of paclitaxel in rat cochlear organotypic cultures. Toxicol Appl Pharm. 280(3):526–533. doi:10.1016/j.taap.2014.08.022.
  • Fant J, S B H, Schiff PB. 1979. Promotion of microtubule assembly in vitro by taxol. Nature. 277(5698):665–667. doi:10.1038/277665a0.
  • Hirose Y, J A S, Ou HC. 2011. Hair cell toxicity in anti-cancer drugs: evaluating an anti-cancer drug library for independent and synergistic toxic effects on hair cells using the zebrafish lateral line. J Assoc Res Otolaryngol. 12(6):719–728. doi:10.1007/s10162-011-0278-z.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.